Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IQV · against 1,336 other Healthcare companies
Ranked #529 of 1,337 · scores higher than 60% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including IQV · Click a bar to see the companies
Mainly thanks to its free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | IQV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.1% | 1.5% | 63% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 5.3% | 4.2% | 57% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 5.1% | -1.0% | 79% | 20% | |
| Book yieldHigher is better · 1,306 reported | 14.3% | 37.9% | 20% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 529 | 21.4B USD | 60 | 67 | |
| 529 | 249.4B USD | 60 | 55 | |
| 529 | 77.1B DKK (≈$11.6B) | 60 | 47 | |
| 529 | 1.1B USD | 60 | 43 | |
| 529 | 43.2B USD | 60 | 45 | |
| 529 | 148.7B INR (≈$1.8B) | 60 | 48 | |
| 529 | 5.0B USD | 60 | 60 | |
| 529 | 10.7B USD | 60 | 65 | |
| 529 | 365M EUR (≈$401M) | 60 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score